Detail akcie IQVIA Holdings Rg online

Business Summary: IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Iqvia Holdings Inc revenues increased 2% to $3.83B. Net income decreased 14% to $249M. Revenues reflect Technology & Analytics Solutions segment increase of 6% to $1.55B, Research & Development Solutions segment remaining flat at $2.1B, Europe & Africa Region segment increase of 6% to $1.22B, Asia Pacific Region segment increase of 3% to $798M, Americas segment increase of less than 1% to $1.81B.